Ionis Pharmaceuticals Income from Continuous Operations 2010-2024 | IONS

Ionis Pharmaceuticals income from continuous operations for the twelve months ending September 30, 2024 was $-0.359B, a 12.37% decline year-over-year.

  • Ionis Pharmaceuticals annual income from continuous operations for 2023 was $-0.366B, a 35.8% increase from 2022.
  • Ionis Pharmaceuticals annual income from continuous operations for 2022 was $-0.27B, a 843.18% increase from 2021.
  • Ionis Pharmaceuticals annual income from continuous operations for 2021 was $-0.029B, a 94.04% decline from 2020.

Ionis Pharmaceuticals Income from Continuous Operations 2010-2024 | IONS

  • Ionis Pharmaceuticals annual income from continuous operations for 2023 was $-0.366B, a 35.8% increase from 2022.
  • Ionis Pharmaceuticals annual income from continuous operations for 2022 was $-0.27B, a 843.18% increase from 2021.
  • Ionis Pharmaceuticals annual income from continuous operations for 2021 was $-0.029B, a 94.04% decline from 2020.